NCT04879992View on ClinicalTrials.gov

Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori

NACompletedINTERVENTIONAL
Enrollment

413

Participants

Timeline

Start Date

May 7, 2021

Primary Completion Date

October 14, 2022

Study Completion Date

October 30, 2022

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Esomeprazole

Proton pump inhibitor

DRUG

Bismuth Potassium Citrate

Gastric mucosal protective drug with anti-H. pylori effect

DRUG

Tetracycline,Metronidazole

Antibiotics for H. pylori eradication

DRUG

amoxicillin rifabutin

Antibiotics for H. pylori eradication

Trial Locations (1)

200127

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER